日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

RNA binding protein Pcbp1 maintains mitochondria integrity to promote antibody production and germinal center response.

RNA结合蛋白Pcbp1维持线粒体的完整性，从而促进抗体产生和生发中心反应。

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.adz9095
Zhu Lizhen, Lin Li, Qi Tuan, Li Geng, Liang Zhixing, Yu Jiancheng, Fu Yifan, Peng Yue, Chang Xing
心血管
CBP
线粒体
发表日期：2026
文献求助 收藏

CRSP8-driven fatty acid metabolism reprogramming enhances hepatocellular carcinoma progression by inhibiting RAN-mediated PPARα nucleus-cytoplasm shuttling.

CRSP8 驱动的脂肪酸代谢重编程通过抑制 RAN 介导的 PPARα 核质穿梭来增强肝细胞癌的进展

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03329-3
Lin Yuxi, Liang Zhixing, Weng Zhiyan, Liu Xiaofang, Zhang Feng, Chong Yutian
代谢
细胞生物学
代谢重编程
发表日期：2025
文献求助 收藏

FXR-mediated antigen-specific CD8(+) T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma

FXR介导的抗原特异性CD8(+) T细胞增强肝内胆管癌的抗肿瘤免疫

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-012259
Liu, Shanshan; Liang, Zhixing; Zhu, Lisi; Zheng, Yuhao; Yu, Haoyuan; Ye, Shusen; Liang, Texi; Huang, Linzi; Ouyang, Jiayi; Cao, Yingjiao; Ye, Lilin; Ye, Linsen
肿瘤
T细胞
肿瘤免疫
CD8
T细胞
胆管癌
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Norcantharidin/Cu(2+) dual-depleting GSH nanocatalyst with pH-responsive for CT/CDT synergistic cancer therapy

用于CT/CDT协同癌症治疗的pH响应型去甲斑蝥素/Cu(2+)双重耗竭GSH纳米催化剂

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2025.101959
Guo, Xiaohuan; Cai, Bingbing; Fang, Qi; Chen, Yanyan; Zhou, Yuzhu; Liang, Zhixing; Wen, Changchun; Liu, Yan-Cheng; Liang, Hong
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion

组织驻留外周辅助性T细胞通过促进调节性B细胞扩增来促进肝细胞癌的免疫逃逸。

期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003544
Yu, Haoyuan; Shi, Mengchen; Li, Xuejiao; Liang, Zhixing; Li, Kun; Hu, Yongwei; Li, Siqi; Zhang, Mingshen; Yang, Yang; Li, Yang; Ye, Linsen
B细胞
肿瘤
T细胞
肿瘤免疫
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies

免疫检查点抑制剂在肝细胞癌治疗中的应用：耐药机制、肝移植挑战及管理策略

期刊:Cancer Drug Resistance
影响因子:5.2
doi:10.20517/cdr.2025.120
Chen, Yutao; Chen, Desheng; Liang, Zhixing; Yu, Haoyuan; Sun, Haobin; Hu, Yongwei; Jiang, Peng; Zhang, Mingshen; Ye, Linsen; Li, Hua
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Association between changes in body composition and progression of liver fibrosis in patients with type 2 diabetes mellitus

2型糖尿病患者体成分变化与肝纤维化进展之间的关联

期刊:Frontiers in Nutrition
影响因子:5.1
doi:10.3389/fnut.2024.1476467
Lin, Yuxi; Liang, Zhixing; Liu, Xiaofang; Chong, Yutian
糖尿病
代谢
发表日期：2024
文献求助 收藏

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation

替诺福韦与恩替卡韦在降低肝移植后乙型肝炎病毒相关肝细胞癌复发风险方面的比较

期刊:Infectious Agents and Cancer
影响因子:2.8
doi:10.1186/s13027-022-00478-4
Yang, Jianming; Chen, Yewu; Sun, Haobin; Zhang, Xijian; Wang, Jianfeng; Liang, Zhixing; Fu, Binsheng; Zhang, Tong; Yi, Shuhong; Deng, Yinan; Yang, Yang
肿瘤
肿瘤免疫
微生物学
细胞生物学
肝炎
发表日期：2023
文献求助 收藏

Novel organoid model in drug screening: Past, present, and future

新型类器官模型在药物筛选中的应用：过去、现在和未来

期刊:Liver Research
影响因子:2.1
doi:10.1016/j.livres.2021.05.003
Nie, Xialin; Liang, Zhixing; Li, Kun; Yu, Haoyuan; Huang, Yuhan; Ye, Linsen; Yang, Yang
3D/类器官
发表日期：2021
文献求助 收藏